We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Millipore and JPT Announces Distribution Agreement

Millipore and JPT Announces Distribution Agreement

Millipore and JPT Announces Distribution Agreement

Millipore and JPT Announces Distribution Agreement

Read time:

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Millipore and JPT Announces Distribution Agreement"

First Name*
Last Name*
Email Address*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Millipore Corporation and JPT Peptide Technologies GmbH, a wholly-owned subsidiary of Berlin-based Jerini AG have announced a distribution and marketing agreement.

This relationship gives Millipore worldwide, non-exclusive distribution rights for JPT’s line of enzyme profiling products and services targeting enzymes such as kinases, phosphatases and proteases.

This includes JPT’s line of Enzyme Substrate Sets and Microarrays containing thousands of peptides with annotated phosphorylation/cleavage sites to study enzymatic activities and substrate specificities.

"JPT’s unique peptide-based products strongly complement our existing portfolio of cell signaling reagents and services," states Rick Ryan, vice president of the Drug Discovery business unit for the Bioscience Division of Millipore Corporation.

"This will give Millipore customers access to patented high-throughput peptide synthesis and screening platforms, which accelerates research in the field of signal transduction."

"We applied our peptide synthesis and peptide array technologies to develop a series of tailor-made products and services to address the increasing demand in the field of kinase and protease research," comments Holger Wenschuh, managing director at JPT.

"We look forward to expanding the availability of these tools through Millipore’s worldwide, dedicated sales channels."